Agilent price target lowered to $150 from $160 at Credit Suisse

Credit Suisse analyst Dan Leonard lowered the firm’s price target on Agilent to $150 from $160 and keeps an Outperform rating on the shares. The firm notes Q3 performed above plan except for China and U.S. genomics. While Credit Suisse acknowledges that the magnitude of guide-down is a surprise, the company still sees growth in FY24.